A batch of drugs has been suspended for recall: acetaminophen tablets...

Medicine Network December 8th In recent days, Sichuan, Jilin, Liaoning and Yunnan provinces have issued drug quality announcements, a number of drugs were investigated and suspended for recall.
Chuan: 17 batches of drugs suspended from sale recall December 3, Sichuan Provincial Drug Administration issued a notice that by the Luzhou City Market Inspection and Testing Center and other 12 drug testing institutions, marked as Wuhan Taifu Pharmaceutical Co., Ltd. and other 17 pharmaceutical manufacturers produced 17 batches of drugs do not meet the requirements.
Specifically as follows: combing found that 17 batches of unqualified drugs, only one batch of preparations (nighting particles), the rest are all Chinese medicine tablets, including yams, fresh white skin, hot licorice, mountain silver flowers and so on.
the above-mentioned non-compliant drugs, the drug supervision and administration department has asked relevant enterprises and units to take risk control measures such as suspension of sales and use, recall, etc., to investigate the reasons for non-compliance and to carry out effective rectification.
same time, the Bureau requires the relevant drug regulatory departments, in accordance with the Drug Administration Law of the People's Republic of China, to organize investigations into illegal acts committed by the above-mentioned enterprises and units in the production and sale of counterfeit and inferior drugs, and to publicly investigate and punish the results in accordance with the provisions.
: 9 batches of drugs were investigated on December 3, Jilin Provincial Drug Administration 2020 No. 2 drug quality announcement.
announcement showed that there are 9 batches of drugs do not meet the requirements, of which 3 batches are preparations, respectively, gout wet pills, acetaminophen tablets, deer supplement capsules, the rest are all Chinese herbs and their drink tablets.
, the drug regulatory department has asked the relevant units to take risk prevention and control measures to investigate and punish non-conforming products in accordance with relevant laws and regulations.
: 1 batch of drugs unqualified December 1, Liaoning Provincial Drug Administration issued the 2nd issue of 2020 drug quality bulletin.
in order to strengthen drug quality supervision and ensure the safety of public drug use, according to the 2020 Liaoning Province Drug Sampling Plan, the Liaoning Provincial Drug Administration has carried out drug sampling in the province-wide pharmaceutical production, operation and use units.
a total of 701 batches of drugs, of which, in accordance with the provisions of 700 batches, does not meet the requirements of 1 batch, the pass rate of 99%.
: 7 batches of unqualified drugs November 30, Yunnan Provincial Drug Administration 2020 No. 2 non-conforming drug quality announcement.
are as follows: